“…Interestingly, the co-adjuvant effect of EMD87580 or HMA with paclitaxel was not observed in hormone receptor-positive, luminal MCF-7 cells, or MDA-MB-231 cells lacking NHE1 expression [9]. In our hands, when MDA-MB-231 cells were treated with EMD87580 alone, even at high concentrations (≥ 100 μM), we did not see significant effects 18 on metastatic potential, while HMA alone was cytotoxic at concentrations ≥ 10 μM, so any significant effect on migration and invasion could not be properly assessed (unpublished observations). In contrast, KR-33028 was not cytotoxic at the concentrations used in this study, had a demonstrable inhibition of metastatic potential in these cells, and shows promise as a potential anti-cancer agent.…”